| Pubmed ID |
Author | Year | Title |
26246878 |
Zaree M | 2015 | Expression Levels of PPAR? and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of ?-3 Fatty Acid. |
26248242 |
Iwata MC | 2015 | Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome. |
26254797 |
Ohlsson Gotby A | 2015 | Congenital Adrenal Hyperplasia, Polycystic Ovary Syndrome and criminal behavior: A Swedish population based study. |
26255520 |
Hao C | 2015 | [Acupuncture at Zhibian (BL 54) through Shuidao (ST 28) for polycystic ovary syndrome]. |
26255991 |
Joham AE | 2016 | Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance. |
26257142 |
Jin CH | 2015 | Body fat distribution and its associated factors in Korean women with polycystic ovary syndrome. |
26258078 |
Salama AA | 2015 | Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome. |
26261426 |
Palomba S | 2015 | Complications and challenges associated with polycystic ovary syndrome: current perspectives. |
26264225 |
Figueroa F | 2015 | Role of macrophage secretions on rat polycystic ovary: its effect on apoptosis. |
26265416 |
Ali AT | 2015 | Polycystic ovary syndrome and metabolic syndrome. |
26267328 |
Razavi M | 2016 | Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome. |
26269538 |
Daan NM | 2015 | Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. |
26273622 |
Du T | 2015 | Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome. |
26273679 |
Chuang TY | 2015 | MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue. |
26277181 |
Lis I | 2015 | [Omentin - a newly-discovered adipocytokine in insulin resistance pathogenesis]. |
26279073 |
Jamilian M | 2015 | Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. |
26279758 |
Li D | 2015 | Epigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome. |
26280343 |
Mortada R | 2015 | Metabolic Syndrome: Polycystic Ovary Syndrome. |
26282993 |
Wu S | 2015 | MicroRNA-132 promotes estradiol synthesis in ovarian granulosa cells via translational repression of Nurr1. |
26283014 |
Shi L | 2015 | miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome. |
26284813 |
Hayes MG | 2015 | Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. |
26284937 |
De Fr?ne V | 2015 | Quality of Life and Body Mass Index in Overweight Adult Women with Polycystic Ovary Syndrome During a Lifestyle Modification Program. |
26288062 |
Micussi MT | 2016 | Relationship between pelvic floor muscle and hormone levels in polycystic ovary syndrome. |
26288130 |
Traver S | 2015 | Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes. |
26288196 |
Desai NA | 2015 | Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe? |
26288450 |
Kura MM | 2015 | Acral Acanthosis Nigricans in a Case of Scleroderma. |
26289303 |
Spritzer PM | 2015 | Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. |
26291797 |
Maged AM | 2015 | The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome. |
26291802 |
Aziz M | 2015 | Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation. |
26291804 |
Chun S | 2015 | 1-h Postprandial glucose level is related to the serum anti-M?llerian hormone level in women with polycystic ovary syndrome. |
26291814 |
G?ne? M | 2015 | Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome. |
26291816 |
Yang S | 2016 | Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? |
26292090 |
Agacayak E | 2015 | Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome. |
26294351 |
Amato MC | 2015 | Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. |
26295295 |
Sahin FK | 2015 | Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. |
26298265 |
Seo Y | 2015 | Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome. |
26298524 |
Marzouk TM | 2015 | Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome. |
26298813 |
Scalici E | 2015 | [Circulating nucleic acids and infertility]. |
26299777 |
Nugent D | 2015 | WITHDRAWN: Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. |
26299778 |
Nahuis M | 2015 | WITHDRAWN: Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. |
26304048 |
Huang X | 2015 | A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures. |
26305227 |
Jones MR | 2015 | Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity. |
26306851 |
Walters KA | 2016 | Androgen receptor splice variants and polycystic ovary syndrome: cause or effect? |
26308735 |
Shim U | 2015 | Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome. |
26311969 |
Turan V | 2015 | Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study. |
26312838 |
O'Reilly M | 2015 | Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome. |
26314870 |
Sun X | 2015 | Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin. |
26315293 |
Ortega I | 2015 | Ovarian actions of resveratrol. |
26315303 |
Jamilian M | 2016 | Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. |
26320144 |
Victor VM | 2015 | Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance. |
26321405 |
Pace JL | 2015 | Acne - a potential skin marker of internal disease. |
26322372 |
Hurliman A | 2015 | Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS). |
26323652 |
Wu L | 2015 | Expression and contribution of the HIF-1?/VEGF signaling pathway to luteal development and function in pregnant rats. |
26327459 |
Bui HN | 2015 | Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome. |
26327878 |
Lenart-Lipi?ska M | 2014 | Polycystic ovary syndrome: clinical implication in perimenopause. |
26327890 |
Stachowiak G | 2015 | Metabolic disorders in menopause. |
26330853 |
Moti M | 2015 | Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome. |
26335180 |
Ding Y | 2016 | The Mitochondrial tRNALeu(UUR) A3302G Mutation may be Associated With Insulin Resistance in Woman With Polycystic Ovary Syndrome. |
26335185 |
Bagir GS | 2016 | Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes. |
26339397 |
Tao X | 2015 | Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide. |
26339875 |
Calvar CE | 2015 | [High frequency of thyroid abnormalities in polycystic ovary syndrome]. |
26340353 |
Demir B | 2015 | The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome. |
26340452 |
Karmarkar R | 2015 | Gynaecological pathology in women with Fowler's syndrome. |
26340970 |
Vassilatou E | 2015 | Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease. |
26341109 |
Enkhmaa B | 2015 | Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. |
26345811 |
Pan XY | 2015 | Effect of HIF-1a/VEGF signaling pathway on plasma progesterone and ovarian prostaglandin F?a secretion during luteal development of pseudopregnant rats. |
26348137 |
Wang H | 2015 | Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function. |
26350625 |
Weiss NS | 2015 | Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. |
26351529 |
Tsikouras P | 2015 | Features of Polycystic Ovary Syndrome in adolescence. |
26354094 |
Kuang H | 2015 | Predictors of participant retention in infertility treatment trials. |
26354095 |
Kenigsberg LE | 2015 | Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls. |
26357661 |
Liu X | 2015 | Paracrine Regulation of Steroidogenesis in Theca Cells by Granulosa Cells Derived from Mouse Preantral Follicles. |
26358939 |
Coles N | 2016 | Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome. |
26359323 |
De Laveleye M | 2015 | Anti-M?llerian hormone testing: Evaluation of a novel method allowing more automation. |
26360506 |
Homa LD | 2015 | Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS). |
26360602 |
Ramezani Tehrani F | 2015 | Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study. |
26361992 |
Unlu E | 2016 | Adrenal gland volume assessed by magnetic resonance imaging in women with polycystic ovary syndrome. |
26364227 |
Tavakolian Arjmand A | 2015 | Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus. |
26366087 |
Yang YM | 2015 | Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome. |
26368511 |
K???? A | 2016 | Clitoral and labial sizes in women w?th PCOS. |
26369257 |
Taskin MI | 2016 | NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome. |
26370242 |
Casarini L | 2015 | Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success. |
26370491 |
Jia XZ | 2015 | Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis. |
26370557 |
Sawada M | 2015 | Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome. |
26370923 |
Diri H | 2016 | Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome. |
26371381 |
Gourgari E | 2015 | Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk. |
26372304 |
Churchill SJ | 2015 | Metabolic consequences of polycystic ovary syndrome. |
26373789 |
Lin T | 2015 | Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study. |
26373822 |
Dantas WS | 2015 | GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome. |
26373866 |
Kartal D | 2016 | Association between isolated female acne and insulin resistance: a prospective study. |
26376770 |
Anastasia K | 2015 | Association of Calpain (CAPN) 10 (UCSNP-43, rs3792267) gene polymorphism with elevated serum androgens in young women with the most severe phenotype of polycystic ovary syndrome (PCOS). |
26382159 |
Holloway V | 2015 | Sex drive and sexual desire. |
26383179 |
Godoy-Gij?n E | 2016 | [New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases]. |
26384054 |
Dag ZO | 2015 | Autonomic dysfunction in patients with polycystic ovary syndrome. |
26384059 |
Ko PC | 2015 | Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women. |
26386293 |
Usadi RS | 2015 | Recruitment strategies in two reproductive medicine network infertility trials. |
26386695 |
Pertynska-Marczewska M | 2015 | Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome? |
26387454 |
Huang R | 2015 | Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume. |
26387747 |
Cheng F | 2016 | Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment. |
26387977 |
Boyle JA | 2015 | Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women. |
Showing 12,901–13,000 of 14,368